Delivery Order HHSN272201600008I-75N93020F00001
Award Date
5/1/20
Potential Completion Date
7/14/22
Potential Value
$1.4M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Advanced Bioscience Laboratories, Inc., doing business as Advanced Bioscience Laboratories Inc., has been awarded an $893,336 cost-plus-fixed-fee delivery order against the HIV Microbicides and Biomedical Prevention 2016-2021 master indefinite-delivery/indefinite-quantity contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this award, the contractor will provide expertise in the development and optimization of antiretroviral therapy for...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The $3,150,428.64 award is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL will provide comprehensive resources for HIV...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $1,529,440.80 cost-plus-fixed-fee contract provides statistical support for HIV non-vaccine biomedical prevention product development under NIAID's "Comprehensive Resources for HIV Microbicides and Biomedical Prevention"...
This task order funds the guaranteed minimum amount under a preexisting master indefinite-delivery/indefinite-quantity contract between the National Institutes of Health's National Institute of Allergy and Infectious Diseases and Advanced Bioscience Laboratories, Inc. The purpose is to support preclinical and translational vaccine development for HIV and other candidate agents. The $2,500 delivery order was awarded on December 1, 2021 with a one-year period of performance ending November 30,...
This federal contract award, valued at $1,278,579.71, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract supports statistical and pharmacometric modeling for the development of HIV non-vaccine biomedical prevention products under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical...
This federal contract award, valued at $572,349.48, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for material receipt, storage, shipping, and inventory services to support NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This is a Delivery Order under ABL's existing...
This federal contract award, valued at $844,713.24, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for support in enhancing study drug adherence in HIV prevention trials, falling under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The contract is a cost-plus-fixed-fee delivery order under the...
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL). The $533,028.94 contract is for the development of HIV non-vaccine biomedical prevention products, including assessing product attributes, positioning, and messaging to drive adoption and use of new personal use products among young,...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for the provision of expertise in ethnographic research related to the enhancement of study drug adherence and uptake in human immunodeficiency virus (HIV) prevention trials. The contract has a ceiling value of...
This is a $3,017,609 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL) for fill-finish, release, and stability testing of HIV-1 gp120 proteins. The contract has an ultimate completion date of April 15, 2025. ABL is a for-profit organization that specializes in the development of biologics, vaccines, and immunotherapies....